LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or "the Company") (OTC PINK:RBGLY) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024. The verdict was the first lawsuit related to necrotizing enterocolitis ("NEC") that reached a verdict. A second jury awarded $95 million on July 29, 2024, to the plaintiff in a NEC case against the Company’s competitor, Abbott. Based on this news, the Company’s American Depositary Receipts ("ADRs") fell sharply.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
SOURCE: The Schall Law Firm
View the original press release on ACCESS Newswire
COMTEX_463039872/2457/2025-02-22T10:03:31